Mar 5, 2024, 08:41 AM by

Synexa Life Sciences has announced the integration of the Olink® Target immunoassays and the Olink® Signature Q100 instrument into its extensive suite of biomarker discovery platforms.

Mar 5, 2024, 08:41 AM by

VERICHEM LABORATORIES now offers two, distinct multi-level test kits of clinical reference materials for the calibration verification of Lithium assays.

Mar 5, 2024, 08:41 AM by

WCG’s Statistical Consulting Solutions provide statistical support across all stages of clinical trial design and regulatory strategy from protocol reviews to final analyses.

Mar 5, 2024, 01:00 AM by User Not Found

Bio-IT World | The Bio-IT World Conference & Expo has launched a new co-located event this year—the Bio-IT World Venture, Innovation, and Partnering Conference, held on Wednesday, April 17, overlapping with the last day of the Bio-IT World Conference.

Mar 4, 2024, 09:05 AM by

Mental health chatbots are surging in popularity due to the growing need for accessible and convenient care.

Mar 1, 2024, 07:32 AM by

Feb 29, 2024, 08:54 AM by

Feb 29, 2024, 08:54 AM by

Feb 29, 2024, 08:54 AM by

Feb 29, 2024, 08:54 AM by

Feb 29, 2024, 08:54 AM by

Feb 29, 2024, 08:54 AM by

Feb 29, 2024, 08:54 AM by

Neobe Therapeutics, a pioneering synthetic biology startup at the forefront of immuno-oncology innovation, is thrilled to announce the successful closure of a $2.34M financing round.

Feb 29, 2024, 01:00 AM by User Not Found

Bio-IT World | Oxford Nanopore and Lonza have teamed up to cGMP validate and commercialize a first-of-its-kind novel test to accurately determine multiple critical quality attributes of mRNA products by directly sequencing both the DNA template and the messenger RNA; Parse updates whole transcriptome kit; and more.

Feb 28, 2024, 09:00 AM by User Not Found

Bio-IT World | Ginkgo Bioworks announced three acquisitions today: Reverie Labs, Proof Diagnostics, and Patch Biosciences. The acquisitions will expand Ginkgo’s capabilities for large-scale AI foundation models, its library of RNA programmable, non-Cas enzymes, and its machine learning models and downstream assays.

Feb 28, 2024, 07:34 AM by

Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images

Feb 28, 2024, 07:34 AM by

New Kalderos board members bring broad legal, regulatory, and corporate leadership experience across healthcare, biopharmaceutical, and pharmacy industries.

Feb 28, 2024, 07:34 AM by

Optibrium has launched Semeta™, a metabolism prediction platform tailored specifically for drug metabolism and pharmacokinetics (DMPK) scientists. Fundamental to improving a drug’s chance of clinical success, Semeta allows the accurate prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery, with superior precision to comparable software.

Feb 28, 2024, 07:34 AM by

Also, in 2023, Avalon launched Precision Genetic Testing Management (PGTM), the next evolution of its genetic test management solution.

Feb 28, 2024, 07:34 AM by